Literature DB >> 10528899

Surgical therapy of hepatic colorectal metastasis.

Y Fong1, J Salo.   

Abstract

The liver is a common site of metastases from colorectal cancer. The data are convincing that liver resection is a safe and effective therapy for such metastatic disease. Even extensive resections can be performed with a less than 5% mortality rate at major centers and a 5-year survival rate of 30% to 40%. This review examines factors important for patient selection for liver resection and proposes a prognostic scoring system that may help in patient selection. For unresectable disease, many methods for ablating tumors are now available that will likely prove to be useful adjuncts to current treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10528899

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  26 in total

1.  Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials.

Authors:  Thomas E Clancy; Elijah Dixon; Roy Perlis; Francis R Sutherland; Michael J Zinner
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

2.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.

Authors:  Claudio A Redaelli; Jean-François Dufour; Markus Wagner; Martin Schilling; Jürg Hüsler; Lukas Krähenbühl; Markus W Büchler; Jürg Reichen
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

3.  Portal vein embolisation for extended hepatectomy: single-centre experience.

Authors:  Soumil Vyas; Clare Bent; Stefano Partelli; Ajit T Abraham; Robert R Hutchins; Satyajit Bhattacharya; Deborah Low; Tim Fotheringham; Hemant M Kocher
Journal:  J Gastrointest Cancer       Date:  2012-09

4.  Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.

Authors:  Florian Sterzing; Thomas B Brunner; Iris Ernst; Wolfgang W Baus; Burkhard Greve; Klaus Herfarth; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2014-08-05       Impact factor: 3.621

5.  Strategies for Management of Synchronous Colorectal Metastases.

Authors:  Jason A Castellanos; Nipun B Merchant
Journal:  Curr Surg Rep       Date:  2014-06-01

6.  The hippurate ratio as an indicator of functional hepatic reserve for resection of hepatocellular carcinoma in cirrhotic patients.

Authors:  A W Hemming; S Gallinger; P D Greig; M S Cattral; B Langer; B R Taylor; Z Verjee; E Giesbrecht; Y Nakamachi; K N Furuya
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

Review 7.  Multisciplinary management of patients with liver metastasis from colorectal cancer.

Authors:  Kathleen De Greef; Christian Rolfo; Antonio Russo; Thiery Chapelle; Giuseppe Bronte; Francesco Passiglia; Andreia Coelho; Konstantinos Papadimitriou; Marc Peeters
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

8.  Surgical treatment of liver metastases from colorectal cancer in elderly patients.

Authors:  Gianluca Mazzoni; Adriano Tocchi; Michelangelo Miccini; Elia Bettelli; Diletta Cassini; Monica De Santis; Lidia Colace; Stefania Brozzetti
Journal:  Int J Colorectal Dis       Date:  2006-03-15       Impact factor: 2.571

9.  Differences in Perioperative Outcomes Between Right and Left Hepatic Lobectomy.

Authors:  Jeffrey Douaiher; Mashaal Dhir; Lynette Smith; Chandrakanth Are
Journal:  Indian J Surg Oncol       Date:  2015-09-11

Review 10.  Risks and benefits with bevacizumab: evidence and clinical implications.

Authors:  Carla Kurkjian; Edward S Kim
Journal:  Ther Adv Drug Saf       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.